HGSI announced on 1/23 that they changed the dosing of their Hepatitis-C drug during late stage trials. Possibly an overreaction and now the recovery? <a href="http://www.reuters.com/article/rbssHealthcareNews/idUSBNG32509920080123" target="_blank">http://www.reuters.com/article/rbssHealthcareNews/idUSBNG32509920080123</a>